Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Voyager Therapeutics (VYGR) Return on Invested Capital: 2023-2024

Historic Return on Invested Capital for Voyager Therapeutics (VYGR) over the last 1 years, with Sep 2024 value amounting to 0.03%.

  • Voyager Therapeutics' Return on Invested Capital fell 20.00% to 0.03% in Q3 2024 from the same period last year, while for Sep 2024 it was 0.03%, marking a year-over-year decrease of 20.00%. This contributed to the annual value of 0.82% for FY2023, which is N/A change from last year.
  • Latest data reveals that Voyager Therapeutics reported Return on Invested Capital of 0.03% as of Q3 2024, which was up 244.06% from -0.02% recorded in Q2 2024.
  • Voyager Therapeutics' 5-year Return on Invested Capital high stood at 0.67% for Q1 2023, and its period low was -0.02% during Q2 2024.
  • For the 2-year period, Voyager Therapeutics' Return on Invested Capital averaged around 0.32%, with its median value being 0.32% (2023).
  • Data for Voyager Therapeutics' Return on Invested Capital shows a maximum YoY plummeted of 43bps (in 2024) over the last 5 years.
  • Over the past 2 years, Voyager Therapeutics' Return on Invested Capital (Quarterly) stood at 0.59% in 2023, then declined by 20bps to 0.03% in 2024.
  • Its last three reported values are 0.03% in Q3 2024, -0.02% for Q2 2024, and 0.59% during Q4 2023.